That is, T2DM is characterized in the first step by the fact that insulin action is impaired and pancreatic β-cells need to synthesize and secrete more insulin to compensate for this IR state, which could lead to hyperinsulinemia. The gene discussed is INS; the disease is hyperinsulinism.